Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Rivian Automotive And Carvana Were Among The 10 Biggest Large Cap Gainers Last Week (June 23-June 29): Are These In Your Portfolio?

Author: Lekha Gupta | June 30, 2024 12:57pm

These ten large-cap stocks were the best performers in the last week. Are they in your portfolio?

  1. Rivian Automotive, Inc. (NASDAQ:RIVN) shares surged 30.04%  in the last week following a report suggesting the company has simplified its output, cut costs and announced plans for a joint venture with Volkswagen.
  2. Carnival Plc (NYSE:CUK) stock gained 17.78% on continued strength following better-than-expected Q2 earnings.
  3. FedEx Corporation (NYSE:FDX) stock soared 17.51% in the last week on better-than-expected Q4 financial results and guidance. Also, the company announced it expects to buy back $2.5 billion worth of stock in FY25. Several analysts raised the price forecasts on the stock.
  4. Samsara Inc. (NYSE:IOT) stock advanced 16.37% after RBC Capital reiterated an Outperform rating and maintained its price target of $47.
  5. Suzano S.A. (NYSE:SUZ) shares rose 12.24% after it dropped the acquisition pursuit of International Paper Co. (NYSE:IP).
  6. Carvana Co. (NYSE:CVNA) shares increased 11.93% after updating on its operating plan and capital structure at the William Blair 44th Annual Growth Stock Conference in early June.
  7. FTAI Aviation Ltd. (NASDAQ:FTAI) stock gained 11.55% in the last week.
  8. Reddit, Inc. (NYSE:RDDT) shares surged 11.08% after the company announced a policy update to block automated website scraping.
  9. Mongodb Inc (NASDAQ:MDB) stock gained 10.57% in the last week.
  10. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) shares rose 10.82% amid possible continued strength after the company announced topline results from its HELIOS-B Phase 3 study of vutrisiran. Also, multiple analyst firms raised their price forecasts on the stock.

Read Next:

Photo Courtesy of Rivian

Posted In: ALNY CUK CVNA FDX FTAI IOT IP MDB MSTR RDDT RIVN SUZ